5-MeO-DMT

From WikiMD's WELLNESSPEDIA

5-MeO-DMT.svg

Psychedelic tryptamine compound

Chemical Compound
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms [[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704 [[File:|50px]]
References

5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine) is a naturally occurring psychedelic of the tryptamine class. It is found in a variety of plant species and in the venom of the Colorado River toad (Incilius alvarius). It is structurally related to DMT (N,N-dimethyltryptamine) and bufotenin (5-HO-DMT).

Chemistry[edit]

5-MeO-DMT is a tryptamine derivative, featuring a methoxy group at the fifth position of the indole ring. Its chemical formula is C13H18N2O, and it has a molecular weight of 218.30 g/mol. The compound is typically a white to off-white crystalline solid.

Pharmacology[edit]

5-MeO-DMT acts as a serotonin receptor agonist, primarily at the 5-HT2A receptor. It is known for its rapid onset and short duration of action, typically lasting between 30 to 45 minutes when smoked or vaporized. The effects are often described as intense and can include hallucinations, euphoria, and mystical experiences.

Usage[edit]

5-MeO-DMT has been used in shamanic practices and modern psychedelic therapy. It is often vaporized or smoked, but it can also be insufflated or taken orally with a monoamine oxidase inhibitor (MAOI).

Legal Status[edit]

The legal status of 5-MeO-DMT varies by country. In the United States, it is classified as a Schedule I controlled substance under the Controlled Substances Act. In other countries, it may be regulated differently or remain unscheduled.

Safety and Risks[edit]

The use of 5-MeO-DMT carries potential risks, including psychological distress, tachycardia, and hypertension. It is advised to use the substance in a controlled setting with proper harm reduction practices.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.